Medicaments with a high degree of solubility and method for thei

Details Medicaments with a high degree of solubility and method for thei Medicaments with a high degree of solubility and method for thei

1984-08-31

1986-09-09

Rose, Shep K.

Drug, bio-affecting and body treating compositions

Lymphokine

A61K 3179, A61K 900, A61K 31505

Patent

active

046108750

ABSTRACT:
The present invention relates to medicaments with a high degree of dissolution rate and solubility. These medicaments are characterized in that they are in amorphous form produced by spraying in the presence of a stabilizer and of an agent inhibiting the formation of crystals.

REFERENCES:
patent: 4127647 (1978-11-01), Sato et al.
patent: 4151273 (1979-04-01), Riegelman et al.
patent: 4327080 (1982-04-01), Wong et al.
patent: 4343789 (1982-08-01), Kawata et al.
patent: 4344934 (1982-08-01), Martin et al.
patent: 4404183 (1983-09-01), Kawata et al.
patent: 4562069 (1985-12-01), Hegasy et al.
Newton, J. M., "Spray Drying and Its Application in Pharmaceuticals", Manufacturing Chemist and Aerosol News, pp. 33-36 (Apr., 1966).
Keiji Yamamoto, et al, "Dissolution Behavior and Bioavailability of Phenytoin from a Ground Mixture with Microcrystalline Cellulose," J. Pharm. Sci., 65 (10) at 1484-1488 (Oct. 1976).
Chem. Abstract 95: 156593+(1981) re: Japan 81 55370.
Patent Abstract Japan Appl. No. 54-123216 (4-28-81).
Kuhnert et al, C.A. 97:28495s (1982) of Sci. Pharm. 1982 50(1):3-11.
Kuhnert et al, C.A. 98:132438q (1983) of Sci. Pharm. 1982 50(4):324-331.
Elan Corp. Ltd., C.A. 99:76892q (1983) of Belg. 894942, 09 May 1983.
Luger, C.A. 99:167375q (1983) of Acta Crystallorg. Sect. C: Cryst. Struct. Commun. 1983, C3g(10), 1454-8.
Haleblian Chem. Abstr. 83: 136757y (1975) of J. Pharm. Sci. (1975) 64(8):1269-1288, Characterization of Habit and Crystalline Modification of Solids and Their Pharmaceutical Applications.
Beyer, C.A. 89 #152645Q (1978) of Acta Pharm. Technol. (1978) 24(2):171-174.
Kala et al, C.A. 95 #12664u (1981) of Pharmazie (1981) 36(2):106-111.
Nuernberg et al, C.A. 91 #9445k (1979) of Acta Pharm. Technol. (1979) 25(1):49-63.
Junginger, C.A. 85 #130430f (1976) of Pharm. Ind. (1976) 38(5):461-471.
Arita et al, C.A. 92 #135314a (1980) of Gekkan Ryuichi (1979) 21(12):2737-45.
Moriyama et al, C.A. 85 #123640w (1976) of Japan Kokai 76 63925, 02 Jun. 1976.
Nuernberg, C.A. 86 #86034 (1977) of Prog. Colloid. Polym. Sci. (1976) 59:55-69.
Lippold et al, C.A. 89 #12145b (1978) of Ger. Offen. 2,634,004, 02 Feb. 1978.
Stupa et al, C.A. 83 #15575d (1975) of J. Pharmaco. Biopharm. 192 2(61):511-524.
O. I. Corrigan and E. M. Holohan, "Amorphous Spray-Dried Hydroflumethiazide-Polyvinylpyrrolidone Systems: Physicochemical Properties," J. Pharm. Pharmacol, 1984, 36:217-221.
A. A. Badawi and A. A. El-Sayed, "Dissolution Studies of Povidone-Sulfathiazole Coacervated Systems", J. Pharm. Sci. 69:492-497 (1980).
Win L. Chiou and Leslie Ekyle, "Differential Thermal, Solubility, and Aging Studies on Various Sources of Digoxin and Digitoxin Powder:Biopharmaceutical Implications", J. Pharma. Sci. 68:1224-1229 (1979).
Win L. Chious and Sidney Riegelman, "Pharmaceutical Applications of Solid Dispersion Systems", J. Pharma. Sci. 60: 1281-1301 (1971).
O. I. Corrigan, M. A. Farvar, and W. I. Higuchi, "Drug Membrane Transport Enhancement Using High Energy Drug Polyvinylpyrrolidone (PVP) Co-Precipitates, Int. J. Pharma. 5:229-238 (1980).
O. I. Corrigan, K. Sabra, and E. M. Holohan, "Physicochemical Properties of Spray Dried Drugs: Phenobarbitone and Hydroflumethiazide", Drug. Dev. Indust. Pharm. 9:1-20 (1983).
O. I. Corrigan, and R. F. Timoney, "The Influence of Polyvinylpyrrolidone on the Dissolution Properties of Hydroflumethiazide", J. Pharm. Pharmacol. 27:759-764 (1975).
H. J. de Nordwall and L. A. K. Staveley, "The Formation and Crystallization of Simple Organic and Inorganic Glasses", Trans. Faraday Soc. 52:1207-1215 (1956).
Hitoshi Sekikawa, Masahiro Nakano, and Takaichi Arita, "Dissolution Mechanisms of Drug-Polyvinylpyrrolidone Coprecipitates in Aqueons Solution", Chem. Pharm. Bull. 27:1223-1230 (1979).
Eli Shefter and K. C. Cheng, "Drug-Polyvinylpyrrolidone (PVP) Dispersions--A Differential Scanning Colorimetric Study", Int. J. Pharm. 6:179-182 (1980).
A. P. Simonelli, S. C. Mehta, and W. J. Higuchi, "Dissolution Rates of High Energy Sulfathiazide--Povidone Coprecipitates II: Characterization of Form of Drug Controlling Its Dissolution Rate via Solubility Studies", J. Pharm. Sci. 65:355-360 (1976).
A. P. Simonelli, S. C. Mehta, and W. I. Higuchi, "Dissolution Rates of High Energy Polyvinylpyrrolidone (PVP)-Sulfathiazole Coprecipitates", J. Pharm. Sci. 58:538-548 (1969).
M. P. Summers, "Glass Formation in Barbiturates and Solid Dispersion Systems of Barbiturates with Citric Acid", J. Pharma. Sci. 67:1606-1610 (1978).

Affiliated with

Also associated with

Rating

Medicaments with a high degree of solubility and method for thei does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Medicaments with a high degree of solubility and method for thei, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicaments with a high degree of solubility and method for thei will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1014839